Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, May 30, 2025.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Strong Uptrend (+100) - XERS is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, XERS continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been UP since Jul 16th, 2024 at 2.5100
The intermediate-term trend has been UP since May 2nd, 2025 at 4.6489
The short-term trend has been UP since May 29th, 2025 at 4.9400
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 5.0100 | 5.0847 | 4.8800 | 4.9350 | -0.1050 |
| Prev. Close | Volume | Bid | Ask | Time |
| 5.0400 | 1424449 | 2025-05-30 15:59:46 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 6.07 | 52wk High Date | 2025-03-26 |
| 52wk Low | 1.96 | 52wk Low Date | 2024-05-30 |
| Average Volume | 2,123,882 | Shares Outstanding | 160,155 |
| Market Cap | 275M | Assets | 315,453,000M |
| Liabilities | 350,581,000M | P/E Ratio | -4.52630000 |
| Volatility | 56.41 |